Institutional investors purchased a net $129.5 thousand shares of SRDX during the quarter ended June 2017 and now own 85.17% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Medical Specialties industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
TRIGRAN INVESTMENTS, INC. Bought 188.1 Thousand shares of SurModics Inc